Project Details
| Short title | A prospective, open label, Phase I first-in-man trial of safety and tolerability of the humanized Clever-1 antibody (Clevegen) |
|---|---|
| Status | Finished |
| Effective start/end date | 17/04/17 → 31/01/19 |
Funding
- FARON PHARMACEUTICALS OY
A prospective, open label, Phase I first-in-man trial of safety and tolerability of the humanized Clever-1 antibody (Clevegen)
- Shetty, Shishir (Principal Investigator)
- Adams, David (Co-Investigator)
- Rowe, Anna (Co-Investigator)
- Ma, Yuk Ting (Co-Investigator)
- Gough, Rich (Co-Investigator)